Synthesis, Docking Studies, and Biological Evaluation of Betti Bases as
Promising Anti-tubercular Agents
作者:Mucheli Muni Venkata Ramana、Poornima Acharya、Nilesh Korgavkar、Ganesh Pavale、Manish Upadhyay
DOI:10.2174/1570180819666220520141039
日期:2023.6
The objective of the study was to divulge the antitubercular properties of Betti base scaffolds. Method: Betti bases were designed, synthesized 4a-4h, 6a-6h, and investigated for their in vitro antitubercular activity using Microplate Alamar Blue assay (MABA) against the MTB-H37Rv strain. Their binding affinity with amino acids was studied by performing molecular docking studies using InhA (PDB ID:
背景:世界范围内结核病 (TB) 的发病率显着增加。广泛耐药结核病 (XDR-TB) 和多重耐药结核病 (MDR-TB) 使得治疗这种由结核分枝杆菌 MTB-H37Rv 菌株引起的分枝杆菌感染更具挑战性。目前对结核病的治疗持续时间长且有副作用。因此,有必要开发化疗时间短、健康危害小、性价比高的新药。目的:本研究的目的是揭示 Betti 底座支架的抗结核特性。方法:设计、合成 4a-4h、6a-6h 的 Betti 碱基,并使用微孔板 Alamar Blue 测定法 (MABA) 研究其对 MTB-H37Rv 菌株的体外抗结核活性。通过使用 MTB-H37Rv 菌株中存在的 InhA(PDB ID:2NSD)进行分子对接研究,研究了它们与氨基酸的结合亲和力。还进行了细胞毒性测定和中性粒细胞功能测试(NFT)。结果:Betti 碱基(4a-4h,6d)对 MTB-H37Rv 菌株的最小抑菌浓度